There are situations where there is no reference price or value for a biological asset; in
this circumstance the fair value will be calculated as updated value of assets’ net expected cash flows. This standard implies that there is always a realistic way of determining fair value; if not, one will consider applying the amortized cost as replacement for the fair value.